Dr Cedric Akwesigye, the managing director of Microhaem Scientific, has called on African countries to invest in local manufacturing of health products to meet rising demand and reduce dependence on imports.
Akwesigye, who founded the Uganda-based manufacturing firm, said the continent stands to gain significant economic value by investing in the health sector.
“There is a lot of economic value when you invest in health because of the huge demand,” he said.
He explained that his decision to establish a manufacturing plant in Uganda in 2021 was driven by the need to bridge gaps in access to essential diagnostic products.
Microhaem Scientific Ltd now produces a range of medical diagnostic kits, including those for HIV, malaria and sickle cell disease.
He noted that the kits have recently been officially launched by the government for use in health facilities under the Buy Uganda, Build Uganda (BUBU) initiative.
Akwesigye urged African countries to reclaim control over their health systems by reducing reliance on imported products and raw materials.
“We must take back our health sovereignty. We should stop importing raw materials and instead manufacture our own products,” he said.
Looking ahead, Akwesigye said his long-term vision is to see Uganda become a continental hub for health product manufacturing.
“Between now and 2030, my dream is for Uganda to become a health products manufacturing hub for Africa, including producing vaccines locally,” he added.
He also acknowledged the role of the government in supporting local investors, particularly in the health sector.
Akwesigye cited tax waivers, incentives and other forms of support as key factors that have enabled the growth of local manufacturing.
